MEROPENEM RESISTANCE CASES
Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
Superbugs on the rise: One lakh lab samples show routine antibiotics no longer effective in IndiaIndia's common infections are becoming untreatable as widely used antibiotics lose efficacy, according to a new ICMR report. Bacteria causi...
Study flags antimicrobial resistance in bloodstream infections in IndiaA recent study in Lancet Regional Health - Southeast Asia warned that rising antimicrobial resistance (AMR) threatens global health goals b...
Habil Khorakiwala on 3 things in the pipeline that can cause a re-rating for WockhardtHabil Khorakiwala says: “We have earlier signed an agreement on a profit-sharing basis for contract manufacturing with Serum Institute to m...
Load More